Monday, February 14, 2022

Children's Health Defense Informed the FDA that the Facts Certainly Fail to Support Vaccinations in the 6 month-60 month age group. Here is our letter

 https://anthraxvaccine.blogspot.com/2022/02/childrens-health-defense-informed-fda.html

February 9, 2022

 

VIA FEDERAL EXPRESS and EMAIL 

 

 

Dear Dr. Janet Woodcock:

 

We write to you on behalf of Children’s Health Defense (CHD), a non-profit organization devoted to the health of people and the planet. We have actively followed your work to evaluate, authorize and approve vaccines for the American public, and particularly children. 

 

We are aware that you are likely to grant Emergency Use Authorization (EUA) of Pfizer’s BioNTech SARS-CoV-2 vaccine for children aged six months up to five years old following your upcoming meeting on February 15, 2022. We are writing to put you on notice that should you recommend this pediatric EUA vaccine to children under five years old, CHD is poised to take legal action against you. CHD will seek to hold you accountable for recklessly endangering this population with a product that has little, no, or even negative net efficacy but which may put them, without warning, at risk of many adverse health consequences, including heart damage, stroke and other thrombotic events and reproductive harms.

 

We briefly outline why such a recommendation would be reckless for nearly 20 million children in the United States, and millions more around the world.

 

  1. There is no COVID emergency for children under five years old. Children have a 99.995% recovery rate and a body of medical literature indicates that almost zero healthy children under five years old have died from COVID.